These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 788152)

  • 1. Structural studies on des-pentapeptide (B26-30)-insulin. I. The preparation and properties of des-pentapeptide-insulin.
    Sci Sin; 1976; 19(3):351-7. PubMed ID: 788152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural studies on des-pentapeptide (B26-30)-insulin. V. High resolution NMR studies.
    Sci Sin; 1976; 19(4):497-504. PubMed ID: 10624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [B-chain shortening of matrix-bound insulin by pepsin, I:Preparation and properties of bovine des-pentapeptide(B26-30) insulin (suthor's transl)].
    Gattner HG
    Hoppe Seylers Z Physiol Chem; 1975 Sep; 356(9):1397-404. PubMed ID: 240771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural studies on des-pentapeptide (B26-30)-insulin. IV. A preliminary investigation on the hydrophobic region by employing a fluorescence probe, 1-p-toluidinylnaphthalene-8-sulphonate.
    Sci Sin; 1976; 19(4):486-96. PubMed ID: 10623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-chain shortening of matrix-bound insulin with pepsin, II. Preparation and properties of camel des-pentapeptide (B26-30)- and des-PheB1-des-pentapeptide (B26-30)- insulin.
    Danho WO; Gattner HG; Nissen D; Zahn H
    Hoppe Seylers Z Physiol Chem; 1975 Sep; 356(9):1405-12. PubMed ID: 1100508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural studies on des-pentapeptide (B26-30)-insulin. III. State of aggregation, tyrosyl environment, and peptide backbone conformation in solution.
    Sci Sin; 1976; 19(4):475-85. PubMed ID: 10622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation and properties of des-(pentapeptide-B26-30)-insulin].
    Shvachkin IuP; Shmeleva GA; Krivtsov VF; Fedotov VP; Ivanova AI
    Biokhimiia; 1972; 37(5):966-73. PubMed ID: 4564538
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural studies on des-pentapeptide (B26-30)-insulin. II. Growth of crystals and preliminary crystallographic observations.
    Sci Sin; 1976; 19(3):358-61. PubMed ID: 968479
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzyme-assisted semisynthesis of shortened B26-modified insulins.
    Sievert D; Gattner HG; Lenz V; Höcker H
    Biomed Biochim Acta; 1991; 50(10-11):S197-200. PubMed ID: 1820045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical synthesis of [des(tetrapeptide B27--30), Tyr(NH2)26-B] and [des(pentapeptide B26--30), Phe(NH2)25-B] bovine insulins.
    Cosmatos A; Ferderigos N; Katsoyannis PG
    Int J Pept Protein Res; 1979; 14(5):457-71. PubMed ID: 395118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
    Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
    Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The solution structure of a superpotent B-chain-shortened single-replacement insulin analogue.
    Kurapkat G; Siedentop M; Gattner HG; Hagelstein M; Brandenburg D; Grötzinger J; Wollmer A
    Protein Sci; 1999 Mar; 8(3):499-508. PubMed ID: 10091652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Partial synthesis and properties of des-A1-glycine-insulin (author's transl)].
    Brandenburg D; Biela M; Herbertz L; Zahn H
    Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):961-79. PubMed ID: 1237459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An insulin with the native sequence but virtually no activity.
    Wollmer A; Gilge G; Brandenburg D; Gattner HG
    Biol Chem Hoppe Seyler; 1994 Mar; 375(3):219-22. PubMed ID: 8011179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of des(tetrapeptide B(1-4)) and des(pentapeptide B(1-5)) human insulins. Two biologically active analogues.
    Schwartz G; Katsoyannis PG
    Biochemistry; 1978 Oct; 17(21):4550-6. PubMed ID: 718857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the insulin-IGF-I intermediate structures: functional and structural properties of the [TyrB25NMePheB26] insulin mutant.
    Záková L; Brynda J; Au-Alvarez O; Dodson EJ; Dodson GG; Whittingham JL; Brzozowski AM
    Biochemistry; 2004 Dec; 43(51):16293-300. PubMed ID: 15610023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
    Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
    Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A synthetic fragment of insulin with insulin-like biological activity].
    Prozorovskiĭ VN; Maksimova EM; Alekseeva AE; Grebenshchikova OG; Abakumova OIu; Kutsenko NG; Tsvetkova TA; Archakov AI
    Vopr Med Khim; 1996; 42(4):284-91. PubMed ID: 9254511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin receptors-a review (author's transl)].
    Freychet P
    Diabete Metab; 1975 Mar; 1():57-68. PubMed ID: 791721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.